Supor
Analyst
Truist
Equibles does not estimate personal net worth.
About Supor
Supor is recorded as Analyst at Truist. Supor has spoken on 1 investor event across 1 company, most recently for Arcus Biosciences, Inc. on October 20, 2026. The companies whose calls Supor spoke on are classified in the Healthcare sector.
Supor on recent calls
“Thanks for the rationale for why Cas plus capital could extend OS despite some more similar PFS. I'm just curious if you have post-progression data of sequence therapy, post-progression data in Act 20 to support the hypothesis.”
Affiliation history
-
Truist
Analyst
Transcript header (unverified)
Current